Da‐Lei Zhou

488 total citations
24 papers, 352 citations indexed

About

Da‐Lei Zhou is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Da‐Lei Zhou has authored 24 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Da‐Lei Zhou's work include Cancer-related gene regulation (4 papers), RNA modifications and cancer (3 papers) and Viral-associated cancers and disorders (3 papers). Da‐Lei Zhou is often cited by papers focused on Cancer-related gene regulation (4 papers), RNA modifications and cancer (3 papers) and Viral-associated cancers and disorders (3 papers). Da‐Lei Zhou collaborates with scholars based in China, United States and Japan. Da‐Lei Zhou's co-authors include Caiyun He, Zu‐Lu Ye, Cuiling Qi, Lijing Wang, Qianqian Zhang, Jianwei Dai, Xuan Su, Xiaodong He, Qianqian Zhang and Jiangjun Ma and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Gene.

In The Last Decade

Da‐Lei Zhou

23 papers receiving 350 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Da‐Lei Zhou China 11 153 122 89 66 49 24 352
Lizhe Zhu China 12 192 1.3× 110 0.9× 104 1.2× 41 0.6× 119 2.4× 37 381
Mohamed Mabed Egypt 12 127 0.8× 93 0.8× 46 0.5× 111 1.7× 27 0.6× 41 401
Cuiping Zhang China 11 184 1.2× 63 0.5× 79 0.9× 63 1.0× 25 0.5× 43 371
Mengjie Yan China 7 191 1.2× 122 1.0× 90 1.0× 51 0.8× 40 0.8× 10 422
Shunhua Lao United States 6 141 0.9× 228 1.9× 43 0.5× 192 2.9× 43 0.9× 7 466
Dan He China 9 175 1.1× 45 0.4× 58 0.7× 58 0.9× 70 1.4× 38 329
Yugang Wang United States 10 132 0.9× 157 1.3× 103 1.2× 89 1.3× 142 2.9× 19 386
Feiya Du China 12 284 1.9× 80 0.7× 199 2.2× 21 0.3× 33 0.7× 16 428
Yongsu Ma China 12 149 1.0× 196 1.6× 108 1.2× 48 0.7× 75 1.5× 31 374

Countries citing papers authored by Da‐Lei Zhou

Since Specialization
Citations

This map shows the geographic impact of Da‐Lei Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Da‐Lei Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Da‐Lei Zhou more than expected).

Fields of papers citing papers by Da‐Lei Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Da‐Lei Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Da‐Lei Zhou. The network helps show where Da‐Lei Zhou may publish in the future.

Co-authorship network of co-authors of Da‐Lei Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Da‐Lei Zhou. A scholar is included among the top collaborators of Da‐Lei Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Da‐Lei Zhou. Da‐Lei Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Su, Xuan, Da‐Lei Zhou, Qing Liu, et al.. (2022). A diagnostic and predictive lncRNA lnc-MPEG1-1 promotes the proliferation and metastasis of papillary thyroid cancer cells by occupying miR-766-5p. Molecular Therapy — Nucleic Acids. 28. 408–422. 10 indexed citations
3.
Li, Yue, Da‐Lei Zhou, Qing Liu, et al.. (2022). Gene Polymorphisms of m6A Erasers FTO and ALKBH1 Associated with Susceptibility to Gastric Cancer. Pharmacogenomics and Personalized Medicine. Volume 15. 547–559. 9 indexed citations
4.
Yang, Xinhua, et al.. (2022). Inherited rare and common variants in PTCH1 and PTCH2 contributing to the predisposition to reproductive cancers. Gene. 814. 146157–146157. 4 indexed citations
5.
Zhu, Xiaoqin, Wei Li, Jia Zhu, et al.. (2021). Influence of MTHFR C677T and A1298C polymorphisms on the survival of pediatric patients with non-Hodgkin lymphoma. Leukemia & lymphoma. 62(10). 2374–2382. 4 indexed citations
6.
Lü, Suying, Xiaoqin Zhu, Wei Li, et al.. (2021). Influence of Methylenetetrahydrofolate Reductase C677T and A1298C Polymorphism on High-Dose Methotrexate-Related Toxicities in Pediatric Non-Hodgkin Lymphoma Patients. Frontiers in Oncology. 11. 598226–598226. 10 indexed citations
7.
Zhu, Xiaoqin, Jia Zhu, Feifei Sun, et al.. (2021). Influence of UGT1A1 *6/*28 Polymorphisms on Irinotecan-Related Toxicity and Survival in Pediatric Patients with Relapsed/Refractory Solid Tumors Treated with the VIT Regimen. Pharmacogenomics and Personalized Medicine. Volume 14. 369–377. 3 indexed citations
8.
Qiu, Miao‐Zhen, Caiyun He, Xinhua Yang, et al.. (2021). Relationship of HER2 Alteration and Microsatellite Instability Status in Colorectal Adenocarcinoma. The Oncologist. 26(7). e1161–e1170. 13 indexed citations
9.
Su, Xuan, Huichan He, Zu‐Lu Ye, et al.. (2020). A 10-Year Study on Larynx Preservation Compared With Surgical Resection in Patients With Locally Advanced Laryngeal and Hypopharyngeal Cancers. Frontiers in Oncology. 10. 535893–535893. 10 indexed citations
10.
11.
Su, Xuan, Da‐Lei Zhou, Zu‐Lu Ye, et al.. (2020). Polymorphisms in matricellular SPP1 and SPARC contribute to susceptibility to papillary thyroid cancer. Genomics. 112(6). 4959–4967. 10 indexed citations
12.
Li, Yue, Huichan He, Da‐Lei Zhou, et al.. (2020). Associations between lncRNA‐related polymorphisms and hepatocellular carcinoma risk: A two‐stage case–control study. Journal of Gastroenterology and Hepatology. 36(1). 233–239. 2 indexed citations
13.
Qiu, Miao‐Zhen, Caiyun He, Dajun Yang, et al.. (2020). Observational cohort study of clinical outcome in Epstein–Barr virus associated gastric cancer patients. Therapeutic Advances in Medical Oncology. 12. 3863552474–3863552474. 15 indexed citations
14.
Su, Xuan, Da‐Lei Zhou, Zu‐Lu Ye, et al.. (2019). A systematic review and quantitative assessment of methylation biomarkers in fecal DNA and colorectal cancer and its precursor, colorectal adenoma. Mutation Research/Reviews in Mutation Research. 779. 45–57. 33 indexed citations
15.
Su, Xuan, Shu-Wei Chen, Xinhua Yang, et al.. (2019). TSHR rs2288496 associated with thyroid hormone and predict the occurrence of lymph node metastasis of papillary thyroid cancer. Cancer Biomarkers. 26(4). 461–470. 4 indexed citations
16.
Dai, Jianwei, Yuyin Lin, Zixuan Li, et al.. (2017). Andrographolide Inhibits Angiogenesis by Inhibiting the Mir-21-5p/TIMP3 Signaling Pathway. International Journal of Biological Sciences. 13(5). 660–668. 37 indexed citations
17.
Zhang, Qianqian, Jian Chen, Da‐Lei Zhou, et al.. (2017). Dipalmitoylphosphatidic acid inhibits tumor growth in triple-negative breast cancer. International Journal of Biological Sciences. 13(4). 471–479. 11 indexed citations
18.
Zhang, Qianqian, Xiwen Hu, Yilong Liu, et al.. (2015). CD11b deficiency suppresses intestinal tumor growth by reducing myeloid cell recruitment. Scientific Reports. 5(1). 15948–15948. 47 indexed citations
19.
Zhang, Qianqian, Da‐Lei Zhou, Yi Ding, et al.. (2014). Andrographolide inhibits melanoma tumor growth by inactivating the TLR4/NF-κB signaling pathway. Melanoma Research. 24(6). 545–555. 34 indexed citations
20.
Zhang, Qianqian, Da‐Lei Zhou, Lei Yan, et al.. (2014). Slit2/Robo1 signaling promotes intestinal tumorigenesis through Src-mediated activation of the Wnt/β-catenin pathway. Oncotarget. 6(5). 3123–3135. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lizhe Zhu Breakdown of academic impact, for papers by Mohamed Mabed Breakdown of academic impact, for papers by Cuiping Zhang Breakdown of academic impact, for papers by Mengjie Yan Breakdown of academic impact, for papers by Shunhua Lao Breakdown of academic impact, for papers by Dan He Breakdown of academic impact, for papers by Yugang Wang Breakdown of academic impact, for papers by Feiya Du Breakdown of academic impact, for papers by Yongsu Ma
Rankless by CCL
2026